F-1 EX-FILING FEES 0001643918 N/A N/A 0001643918 1 2026-07-14 2026-07-14 0001643918 2 2026-07-14 2026-07-14 0001643918 2026-07-14 2026-07-14 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-1

Biodexa Pharmaceuticals Plc

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Ordinary Shares, GBP 0.000001 per   (1)   Other   638,773,750,000   $ 0.00000509   $ 3,251,358.38   0.0001381   $ 449.01
Fees to be Paid   Equity   Ordinary Shares, GBP 0.000001 per   (2)   Other   638,773,750,000   $ 0.00000509   $ 3,251,358.38   0.0001381   $ 449.01
                                           
Total Offering Amounts:   $ 6,502,716.76         898.02
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 898.02

__________________________________________
Offering Note(s)

(1) American Depositary Shares, or Depositary Shares, issuable upon the deposit of the ordinary shares, nominal value GBP 0.000001 per share, or Ordinary Shares, registered hereby have been registered under a separate Registration Statement on Form F-6 (File No. 333-207186), as amended. Each American Depositary Share represents 500,000 Ordinary Shares.

This registration statement also includes an indeterminate number of shares underlying the Depositary Shares that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended.

Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sales price of the Depositary Shares on the NASDAQ Capital Market on July 9, 2026, divided by 500,000 (to give effect to the 1:500,000 ratio of Depositary Shares to Ordinary Shares).
(2) American Depositary Shares, or Depositary Shares, issuable upon the deposit of the ordinary shares, nominal value GBP 0.000001 per share, or Ordinary Shares, registered hereby have been registered under a separate Registration Statement on Form F-6 (File No. 333-207186), as amended. Each American Depositary Share represents 500,000 Ordinary Shares.

This registration statement also includes an indeterminate number of shares underlying the Depositary Shares that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended.

Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sales price of the Depositary Shares on the NASDAQ Capital Market on July 9, 2026, divided by 500,000 (to give effect to the 1:500,000 ratio of Depositary Shares to Ordinary Shares).